Page 184 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Liver Tumours: Management

P0371 A MULTI-INSTITUTION PHASE II STUDY OF GEMCITABINE/
CISPLATIN/S-1 (GCS) COMBINATION CHEMOTHERAPY
FOR PATIENTS WITH ADVANCED BILIARY TRACT CANCER
(KHBO 1002)
Shogo Kobayashi*, Masashi Kanai, Etsuro Hatano,Yutaka Fujiwara,
Shigeru Marubashi, Atsushi Miyamoto, Hisanori Shiomi, Shoji Kubo,
Shinichi Ikuta, Hiroaki Yanagimoto, Hiroaki Terajima, Hisashi Ikoma,
Daisuke Sakai,Yuzo Kodama, Satoru Seo, Satoshi Morita, Tetsuo Ajiki,
Hiroaki Nagano, Tatsuya Ioka, Japan

P0372 GIDEON: A RETROSPECTIVE ANALYSIS OF PROGNOSTIC
FACTORS FOR SURVIVAL
Jean-Pierre Bronowicki*, Masatoshi Kudo, Riccardo Lencioni, Xiao-
Ping Chen, Lucy Dagher, Junji Furuse, Jean-Francois H. Geschwind,
Laura Ladrón de Guevara, Christos Papandreou, Arun J. Sanyal,
Tadatoshi Takayama, Seung Kew Yoon, Keiko Nakajima, Sheng-Long Ye,
Jorge A. Marrero, France

P0373 TWELVE-YEAR OUTCOMES OF RADIOFREQUENCY
ABLATION AS FIRST LINE TREATMENT FOR
ePOSTERS HEPATOCELLULAR CARCINOMA IN MILAN CRITERIA :
ANALYSIS OF 804 PATIENTS IN A SINGLE CENTER
Se Young Jang, Soo Young Park*, Won Young Tak ,Young Oh Kweon,
Suhyun Lee,Yu Rim Lee, Myung Hi Kim , Seong Jae Yeo, South Korea

P0374 PROGNOSIS OF EARLY-STAGE HEPATOCELLULAR
CARCINOMA : THE CLINICAL IMPLICATION OF SUB-
STAGES OF BARCELONA CLINIC LIVER CANCER SYSTEM
Chien-Wei Su*, Wei-Yu Kao, Chun-Chao Chang, Teh-Ia Huo,
Yi-Hsiang Huang, Han-Chieh Lin, Jaw-Ching Wu, Taiwan

P0375 THE VALIDATION OF HONG KONG LIVER CANCER
STAGING SYSTEM AND COMPARISION WITH BARCELONA
CLINIC LIVER CANCER FOR PREDICTION OF SURVIVAL
AND TREATMENT IN HEPATOCELLULAR CARCINOMA
PATIENTS
Hae Rim Kim*, Ji Hoon Kim,Yang Jae Yoo, Seong Hee Kang,
Young Sun Lee, Sang Jun Suh,Young Kul Jung,Yeon Seok Seo,
Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, South Korea

184 The International Liver Congress™ 2015 • ILC Programme